Amplimmune, based in Rockville, MD, is a biopharmaceutical company dedicated to transforming the future of healthcare through innovative science. Their focus on precision medicine, transformative science, and data-driven approaches aims to unlock the potential of therapies for a range of therapy areas including oncology, immunology, and rare diseases.
With a rich pipeline of next-generation therapeutics and a commitment to sustainability and community support, Amplimmune, in partnership with AstraZeneca, continues to drive advancements in healthcare through cutting-edge research, clinical innovation, and global reach.
Generated from the website